Uploaded September 2021 | Updated September 2026, 2 weeks ago

---

A cardiothoracic surgical team with UofL Health – Jewish Hospital and the University of Louisville has performed the world’s first Aeson bioprosthetic total artificial heart implantation in a female patient. The investigational device, currently intended as a bridge to heart transplant, is part of an Early Feasibility Study (EFS) sponsored by CARMAT, a French medical device company, in partnership with UofL, UofL Health – Jewish Hospital and the UofL Health – Trager Transplant Center.
nam11.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.uoflnews.com%2Fpost%2Fuofltoday%2Ffirst-in-world-heart-implant-woman-receives-novel-type-of-artificial-heart-at-uofl-health-jewish-hospital%2F&data=04%7C01%7Cmike.peak%40louisville.edu%7C775a9e673268492ad4e508d97dd2d75e%7Cdd246e4a54344e158ae391ad9797b209%7C0%7C0%7C637679166767528394%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C1000&sdata=IKJdAWlIILuD%2BsebJ1rsiCphng8iqxDFwEIazn6IMOg%3D&reserved=0